Pilot TMS in Mild TBI
NCT: NCT06999304 · ENROLLING_BY_INVITATION
Brief Summary
Persistent post-concussive symptoms (PPCS) involve an array of physical, cognitive, and behavioral symptoms lasting more than a month after mild traumatic brain injury (mTBI). 34-44% of people with mTBI or concussion present with a considerable burden of PPCS 3-6 months after injury. There is currently no standardized treatment for PPCS, nor FDA approved medication for any neuropsychiatric or neurocognitive symptoms associated with mTBI. Transcranial magnetic stimulation (TMS) shows promise as a treatment for PPCS; however, the current one-size-fits-all approach does not address the heterogeneity of symptoms. We propose utilization of resting state functional MRI (rs-fMRI) guided rTMS to target personalized brain networks burdened with PPCS.
Frequently Asked Questions
What is Pilot TMS in Mild TBI?
Pilot TMS in Mild TBI is a clinical trial registered under NCT06999304. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06999304?
The current status of NCT06999304 (Pilot TMS in Mild TBI) is: ENROLLING_BY_INVITATION.
When did Pilot TMS in Mild TBI start?
Pilot TMS in Mild TBI started on 2025-06-18.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.